Research Study

Glucose Variability in Subclinical Hypertrophy
Principal Investigator 
Graydon S. Meneilly

Overview

Body Locations and Systems 
Disorders and Conditions 
ClinicalTrials.gov# 
NCT02748434
Status 
Recruiting
Study Start/End 
May 30, 2016 to May 30, 2017
Locations 
Diamond Health Care Centre, Research Pavilion
Name/Title 
Gale Tedder, Research Nurse
Phone 
604-875-5115
Email Address 
gale.tedder@vch.ca
Purpose of Study 

Evaluation of insulin absorption at sites affected by clinically apparent lipohypertrophy through short-term continuous glucose monitoring has shown inconsistent results and it is yet unknown how or if subclinical lipohypertrophy affects absorption. In this study investigators propose to enroll at least 20 people who participated in phase 1 and who were determined to have subclinical lipohypertrophy to examine the correlation between glycemic control and amount of insulin injected in subclinical hypertrophic areas using capillary blood glucose and continuous glucose monitoring.

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.